Morgan Stanley Lowers Keurig Dr Pepper (KDP) to Underweight

Morgan Stanley downgraded shares of Keurig Dr Pepper (NYSE:KDP) from an equal weight rating to an underweight rating in a research note published on Thursday, April 11th, Benzinga reports. They currently have $27.30 price target on the stock.

A number of other analysts also recently commented on the company. Barclays restated a buy rating and issued a $31.00 target price on shares of Keurig Dr Pepper in a research note on Tuesday, March 19th. ValuEngine upgraded Keurig Dr Pepper from a strong sell rating to a sell rating in a research note on Monday, February 4th. Zacks Investment Research downgraded Keurig Dr Pepper from a hold rating to a strong sell rating in a research report on Thursday, January 10th. UBS Group assumed coverage on Keurig Dr Pepper in a research report on Thursday, December 13th. They set a buy rating and a $32.00 price target on the stock. Finally, Goldman Sachs Group upgraded Keurig Dr Pepper from a neutral rating to a buy rating and set a $26.35 price target on the stock in a research report on Tuesday, January 8th. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the stock. Keurig Dr Pepper currently has a consensus rating of Hold and a consensus price target of $28.41.

Shares of KDP traded up $0.10 during trading hours on Thursday, hitting $29.05. The company had a trading volume of 2,209,072 shares, compared to its average volume of 2,506,095. The firm has a market cap of $40.88 billion, a price-to-earnings ratio of 27.93, a PEG ratio of 1.58 and a beta of 0.47. The company has a current ratio of 0.38, a quick ratio of 0.27 and a debt-to-equity ratio of 0.64. Keurig Dr Pepper has a one year low of $20.46 and a one year high of $124.36.

Keurig Dr Pepper (NYSE:KDP) last announced its earnings results on Thursday, February 28th. The company reported $0.30 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.30. The company had revenue of $2.81 billion for the quarter, compared to analyst estimates of $2.85 billion. Keurig Dr Pepper had a return on equity of 11.13% and a net margin of 9.53%. On average, equities research analysts forecast that Keurig Dr Pepper will post 1.22 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, April 19th. Shareholders of record on Friday, April 5th were paid a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, April 4th. This represents a $0.60 annualized dividend and a yield of 2.07%. Keurig Dr Pepper’s dividend payout ratio (DPR) is 57.69%.

In other news, insider Brian Andrew Loucks purchased 6,250 shares of the stock in a transaction dated Thursday, March 14th. The stock was acquired at an average cost of $27.34 per share, for a total transaction of $170,875.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Olivier Goudet purchased 20,000 shares of the stock in a transaction dated Friday, March 1st. The shares were purchased at an average price of $25.43 per share, with a total value of $508,600.00. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 46,285 shares of company stock valued at $1,199,274. 0.58% of the stock is owned by insiders.

A number of large investors have recently added to or reduced their stakes in KDP. Versant Capital Management Inc raised its stake in Keurig Dr Pepper by 751.3% in the first quarter. Versant Capital Management Inc now owns 1,328 shares of the company’s stock valued at $37,000 after buying an additional 1,172 shares in the last quarter. Trust Co. of Vermont raised its stake in Keurig Dr Pepper by 177.8% in the first quarter. Trust Co. of Vermont now owns 1,500 shares of the company’s stock valued at $42,000 after buying an additional 960 shares in the last quarter. CENTRAL TRUST Co raised its stake in Keurig Dr Pepper by 3,634.0% in the first quarter. CENTRAL TRUST Co now owns 1,755 shares of the company’s stock valued at $49,000 after buying an additional 1,708 shares in the last quarter. TCI Wealth Advisors Inc. raised its stake in Keurig Dr Pepper by 1,732.4% in the fourth quarter. TCI Wealth Advisors Inc. now owns 2,034 shares of the company’s stock valued at $52,000 after buying an additional 1,923 shares in the last quarter. Finally, Parallel Advisors LLC increased its position in shares of Keurig Dr Pepper by 30.8% during the first quarter. Parallel Advisors LLC now owns 2,317 shares of the company’s stock worth $65,000 after purchasing an additional 546 shares in the last quarter. Hedge funds and other institutional investors own 12.88% of the company’s stock.

About Keurig Dr Pepper

Keurig Dr Pepper Inc engages in the brewing system and specialty coffee businesses in the United States and Canada. The company sources, produces, and sells coffee, hot cocoa, teas, and other beverages in K-Cup, Vue, Rivo, K-Carafe, and K-Mug pods brands; coffee in traditional packaging, including bags and fractional packs; and other specialty beverages in pods.

Featured Article: Stop Order

Analyst Recommendations for Keurig Dr Pepper (NYSE:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.